DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Sano M, Takei M, Shiraishi Y. et al.
Increased hematocrit during sodium-glucose cotransporter 2 inhibitor therapy indicates recovery of tubulointerstitial function in diabetic kidneys.
J Clin Med Res 2016;
8: 844-847
We do not assume any responsibility for the contents of the web pages of other providers.